Rights and permissions
About this article
Cite this article
Infliximab benefits even in nonresponders with RA. Inpharma Wkly. 1490, 15 (2005). https://doi.org/10.2165/00128413-200514900-00030
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128413-200514900-00030